158 related articles for article (PubMed ID: 22751335)
1. Lymphocytic esophagitis: a diagnosis of increasing frequency.
Cohen S; Saxena A; Waljee AK; Piraka C; Purdy J; Appelman H; McKenna B; Elmunzer BJ; Singal AG
J Clin Gastroenterol; 2012; 46(10):828-32. PubMed ID: 22751335
[TBL] [Abstract][Full Text] [Related]
2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
3. How to Approach Lymphocytic Esophagitis.
Nguyen AD; Dunbar KB
Curr Gastroenterol Rep; 2017 Jun; 19(6):24. PubMed ID: 28429201
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
5. Acute dysphagia presentation and its association with esophagitis dissecans and concomitant diseases. A diagnostic challenge.
Teramoto-Matsubara Ó; Galvis-García ES; Abdo-Francis JM; Sobrino-Cossío S; Orozco-Gamiz A; Morales-Arámbula M; Carrasco-Rojas JA; Meza-Caballero M
Cir Cir; 2019; 87(5):572-579. PubMed ID: 31448781
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic Esophagitis: A Case Series of Esophageal Disease with Increasing Frequency.
Yousef M; Chela H; Ertugrul H; Albarrak A; Basar O; Pasha S; Mousa Y; Al Juboori A; Frazier S; Tahan V; Daglilar E
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):79-84. PubMed ID: 36718059
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic esophagitis: Still an enigma a decade later.
Rouphael C; Gordon IO; Thota PN
World J Gastroenterol; 2017 Feb; 23(6):949-956. PubMed ID: 28246468
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.
Watson DI; Lally CJ
World J Surg; 2009 Jan; 33(1):88-94. PubMed ID: 18949510
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis.
Purdy JK; Appelman HD; Golembeski CP; McKenna BJ
Am J Clin Pathol; 2008 Oct; 130(4):508-13. PubMed ID: 18794041
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytic Esophagitis: Current Understanding and Controversy.
Pittman ME
Am J Surg Pathol; 2022 Jan; 46(1):e55-e63. PubMed ID: 33481383
[TBL] [Abstract][Full Text] [Related]
11. Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis.
Basseri B; Levy M; Wang HL; Shaye OA; Pimentel M; Soffer EE; Conklin JL
Dis Esophagus; 2010 Jul; 23(5):368-76. PubMed ID: 20353445
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation.
Sorser SA; Barawi M; Hagglund K; Almojaned M; Lyons H
J Gastroenterol; 2013 Jan; 48(1):81-5. PubMed ID: 22618806
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia.
Pasricha S; Gupta A; Reed CC; Speck O; Woosley JT; Dellon ES
Dig Dis Sci; 2016 Oct; 61(10):2935-2941. PubMed ID: 27343035
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytic Esophagitis With CD4 T-cell-predominant Intraepithelial Lymphocytes and Primary Esophageal Motility Abnormalities: A Potential Novel Clinicopathologic Entity.
Xue Y; Suriawinata A; Liu X; Li Z; Gabbard S; Rothstein R; Lacy B; Lisovsky M
Am J Surg Pathol; 2015 Nov; 39(11):1558-67. PubMed ID: 26379147
[TBL] [Abstract][Full Text] [Related]
15. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
16. Most children with eosinophilic esophagitis have a favorable outcome as young adults.
Bohm M; Jacobs JW; Gupta A; Gupta S; Wo JM
Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 26822685
[TBL] [Abstract][Full Text] [Related]
17. Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
Oda K; Iwakiri R; Hara M; Watanabe K; Danjo A; Shimoda R; Kikkawa A; Ootani A; Sakata H; Tsunada S; Fujimoto K
Dig Dis Sci; 2005 Oct; 50(10):1921-6. PubMed ID: 16187198
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
19. Gender is a determinative factor in the initial clinical presentation of eosinophilic esophagitis.
Lynch KL; Dhalla S; Chedid V; Ravich WJ; Stein EM; Montgomery EA; Bochner BS; Clarke JO
Dis Esophagus; 2016; 29(2):174-8. PubMed ID: 25626069
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
